Correlation Between Praxis Precision and Moderna

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Praxis Precision and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Praxis Precision Medicines and Moderna, you can compare the effects of market volatilities on Praxis Precision and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and Moderna.

Diversification Opportunities for Praxis Precision and Moderna

-0.89
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Praxis and Moderna is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of Praxis Precision i.e., Praxis Precision and Moderna go up and down completely randomly.

Pair Corralation between Praxis Precision and Moderna

Given the investment horizon of 90 days Praxis Precision Medicines is expected to generate 0.81 times more return on investment than Moderna. However, Praxis Precision Medicines is 1.23 times less risky than Moderna. It trades about 0.07 of its potential returns per unit of risk. Moderna is currently generating about -0.3 per unit of risk. If you would invest  7,173  in Praxis Precision Medicines on August 27, 2024 and sell it today you would earn a total of  277.00  from holding Praxis Precision Medicines or generate 3.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Praxis Precision Medicines  vs.  Moderna

 Performance 
       Timeline  
Praxis Precision Med 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Praxis Precision Medicines are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Praxis Precision showed solid returns over the last few months and may actually be approaching a breakup point.
Moderna 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Praxis Precision and Moderna Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Praxis Precision and Moderna

The main advantage of trading using opposite Praxis Precision and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.
The idea behind Praxis Precision Medicines and Moderna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm